{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:23:27Z","timestamp":1767903807900,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00520-022-07214-z","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T14:01:02Z","timestamp":1659016862000},"page":"9707-9709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-9820","authenticated-orcid":false,"given":"Vittorio","family":"Fusco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fasciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Palmeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"7214_CR1","doi-asserted-by":"publisher","unstructured":"Hata H, Imamachi K, Ueda M, Matsuzaka M, Hiraga H, Osanai T, Harabayashi T, Fujimoto K, Oizumi S, Takahashi M, Yoshikawa K, Sato J, Yamazaki Y, Kitagawa Y (2022) Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-022-06839-4. Online ahead of print","DOI":"10.1007\/s00520-022-06839-4"},{"issue":"2","key":"7214_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00520-020-05556-0","volume":"29","author":"TL Ng","year":"2021","unstructured":"Ng TL, Tu MM, Ibrahim MFK, Basulaiman B, McGee SF, Srikanthan A, Fernandes R, Vandermeer L, Stober C, Sienkiewicz M, Jeong A, Saunders D, Awan AA, Hutton B, Clemons MJ (2021) Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Support Care Cancer 29(2):925\u2013943. https:\/\/doi.org\/10.1007\/s00520-020-05556-0","journal-title":"Support Care Cancer"},{"key":"7214_CR3","doi-asserted-by":"publisher","unstructured":"Fasciolo A, Fusco V, De Martino I, Alessio M, Brigo T, Tartara D, Campora RA, Rossi M (2021) Prevention and screening of osteonecrosis of jaw (ONJ): the Alessandria experience of a multidisciplinary team on a 900-patient population. Qeios.\u00a0https:\/\/doi.org\/10.32388\/0QK8E2","DOI":"10.32388\/0QK8E2"},{"key":"7214_CR4","doi-asserted-by":"publisher","unstructured":"Cabras M, Gambino A, Erovigni FM, Della Ferrera F, Freilone R, Pentenero M, Fasciolo A, Di Maio M, Ramieri G, Migliario M, Appendino P, Fusco V (2021) Osteonecrosis of the jaw (ONJ) in cancer and myeloma patients. A 16-year experience of \u201cRete Oncologica Piemonte \u2013 Valle d\u2019Aosta\u201d cancer network. Qeios.  https:\/\/doi.org\/10.32388\/YIVAW8","DOI":"10.32388\/YIVAW8"},{"key":"7214_CR5","doi-asserted-by":"publisher","unstructured":"Cabras M, Gambino A, Conrotto D, Garrone M, Fasciolo A, Basano L, Gilardetti M, Galassi C, Fusco V (2021) Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies. Qeios .  https:\/\/doi.org\/10.32388\/IKLIWH","DOI":"10.32388\/IKLIWH"},{"issue":"10","key":"7214_CR6","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/bjc.2012.385","volume":"107","author":"B Beuselinck","year":"2012","unstructured":"Beuselinck B, Wolter P, Karadimou A, Elaidi R, Dumez H, Rogiers A, Van Cann T, Willems L, Body JJ, Berkers J, Van Poppel H, Lerut E, Debruyne P, Paridaens R, Sch\u00f6ffski P (2012) Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases. Br J Cancer 107(10):1665\u20131671. https:\/\/doi.org\/10.1038\/bjc.2012.385","journal-title":"Br J Cancer"},{"issue":"3","key":"7214_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00520-017-3903-5","volume":"26","author":"T van Cann","year":"2018","unstructured":"van Cann T, Loyson T, Verbiest A, Clement PM, Bechter O, Willems L, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Debruyne PR, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B (2018) Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors. Support Care Cancer 26(3):869\u2013878. https:\/\/doi.org\/10.1007\/s00520-017-3903-5","journal-title":"Support Care Cancer"},{"key":"7214_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-06982-y","author":"V Fusco","year":"2022","unstructured":"Fusco V, Campisi G, Bedogni A (2022) One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of Medication Related Osteonecrosis of the Jaw (MRONJ). Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-022-06982-y","journal-title":"Support Care Cancer"},{"issue":"35","key":"7214_CR9","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/JCO.2017.75.4614","volume":"35","author":"C Van Poznak","year":"2017","unstructured":"Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD, Clemons MJ, Dhesy-Thind SK, Dillmon MS, Eisen A, Frank ES, Jagsi R, Jimenez R, Theriault RL, Vandenberg TA, Yee GC, Moy B (2017) Role of bone-modifying agents in metastatic breast cancer: an American Society of Clinical Oncology-Cancer Care Ontario focused guideline update. J Clin Oncol 35(35):3978\u20133986. https:\/\/doi.org\/10.1200\/JCO.2017.75.4614","journal-title":"J Clin Oncol"},{"issue":"12","key":"7214_CR10","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","volume":"31","author":"R Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland \u00d8, Flamen P, Kurth A, Van Poznak C, Aapro M, Jordan K, ESMO Guidelines Committee (2020) Bone health in cancer: ESMO Clinical Practice Guidelines. Ann Oncol 31(12):1650\u20131663. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.019","journal-title":"Ann Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07214-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07214-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07214-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:18:56Z","timestamp":1669900736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07214-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7214"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07214-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Vittorio Fusco received honoraria as a consultant by Merck; Maura Rossi received travel grants from AAA\/Novartis; other authors declared no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}